2025-07-11 - Analysis Report
Okay, here's an analysis of Teladoc Health Inc. (TDOC) based on the provided data, formatted as requested.

## TDOC: Teladoc Health Inc. Analysis

Teladoc Health Inc. is a telehealth company that provides virtual healthcare services.

### 1. Performance vs. S&P 500 (VOO)

*   **Cumulative Return (TDOC):** -60.78%
*   **Cumulative Return (VOO):** 97.25%
*   **Absolute Divergence:** -156.5
*   **Relative Divergence:** 0.6 (Indicates TDOC's underperformance is near the lowest end of its historical range relative to VOO).

**Analysis:** TDOC has significantly underperformed the S&P 500 (VOO) over the analyzed period. The negative divergence suggests substantial underperformance, and the relative divergence of 0.6 indicates that this underperformance is near its worst compared to its historical range.

#### Alpha, Beta Analysis

| Year       | CAGR     | MDD   | Alpha     | Beta   | Cap(B) |
|------------|----------|-------|-----------|--------|--------|
| 2015-2017  | 76.0%    | 60.6% | 50.0%     | -0.0   | 6.1    |
| 2016-2018  | 128.0%   | 59.3% | 110.0%    | -0.0   | 8.7    |
| 2017-2019  | 176.0%   | 59.3% | 147.0%    | 0.4    | 14.7   |
| 2018-2020  | 237.0%   | 64.0% | 217.0%    | 0.1    | 35.1   |
| 2019-2021  | -83.0%   | 64.0% | -132.0%   | 0.1    | 16.1   |
| 2020-2022  | -295.0%  | 81.3% | -297.0%   | 0.0    | 4.2    |
| 2021-2023  | -488.0%  | 81.3% | -506.0%   | -0.6   | 3.8    |
| 2022-2024  | -111.0%  | 81.3% | -137.0%   | -0.8   | 1.6    |
| 2023-2025  | -32.0%   | 72.9% | -80.0%    | -0.8   | 1.6    |

**Analysis:**

*   **CAGR:** Shows strong growth in earlier periods, but significantly negative in recent periods.
*   **MDD:** High Maximum Drawdown values indicate substantial risk and volatility.
*   **Alpha:** Consistently negative Alpha in recent years suggests underperformance relative to a benchmark.
*   **Beta:** Low Beta values suggest the stock is less sensitive to market movements.
*   **Cap(B):** Market capitalization has significantly decreased, indicating investor concerns and reduced market valuation.

### 2. Recent Stock Price Movements

*   **Current Price:** $8.81
*   **Previous Close:** $8.85
*   **Change:** -0.45%
*   **5-Day Moving Average:** $8.58
*   **20-Day Moving Average:** $7.90
*   **60-Day Moving Average:** $7.37

**Analysis:** The price is slightly down from the previous close. The current price is above all moving averages (5, 20, and 60-day), suggesting a recent upward trend.

### 3. Market Risk Indicator and Other Indices

*   **MRI:** 0.3373 (Low Risk)
*   **RSI:** 70.93 (Approaching overbought territory)
*   **PPO:** 1.08 (Positive momentum)
*   **Hybrid Signal:** Cash 0%, Buy 80% of cash (1 share - Caution - MRI:0.34)
*   **Delta Relative Divergence (20-day):** 0.2 (Short-term increase in relative performance)
*   **Expected Return (%):** -9459.6 (Very negative long-term expectation)

**Analysis:**
*   The MRI indicates low market risk.
*   The RSI is high, suggesting the stock might be overbought in the short term.
*   The PPO indicates positive momentum.
*   The Hybrid Signal suggests caution and a moderate buy recommendation given the MRI.
*   The recent increase in relative divergence is a positive signal.
*   The highly negative expected return suggests significant long-term underperformance relative to the S&P 500.
*   The slight negative change in price from the previous close (-0.45%) isn't substantial enough to indicate a major volatility event.

### 4. Recent News & Significant Events

*   **2025-07-08:** Major business developments, regulatory changes, or market events.
*   **2025-07-07:** Analyst discussions on recent performance and industry trends.
*   **2025-07-11:** Notable stock volatility.
*   **2025-07-10:** Market experts highlight risks and opportunities.

**Analysis:** The news indicates that TDOC is experiencing significant events that are causing volatility and warrant close monitoring.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출        |
|------------|-------|-------------|
| 2025-05-01 | -0.53 | 0.63 B$     |
| 2024-10-31 | -0.19 | 0.64 B$     |
| 2024-08-01 | -4.92 | 0.64 B$     |
| 2024-04-26 | -0.49 | 0.65 B$     |
| 2025-05-01 | -0.49 | 0.65 B$     |

**Analysis:** The company is consistently reporting negative EPS. While revenue has been relatively stable around $0.63-$0.65 billion, the inability to turn a profit is concerning. The significantly large negative EPS in 2024-08-01 indicates a particularly poor quarter, possibly due to write-downs or other unusual expenses.

### 6. Financial Information

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-03-31   | $0.63B  | 68.73%        |
| 2024-12-31   | $0.64B  | 70.50%        |
| 2024-09-30   | $0.64B  | 71.94%        |
| 2024-06-30   | $0.64B  | 70.73%        |
| 2024-03-31   | $0.65B  | 69.89%        |

| Quarter      | Equity | ROE       |
|--------------|---------|-----------|
| 2025-03-31   | $1.43B  | -6.52%    |
| 2024-12-31   | $1.49B  | -3.25%    |
| 2024-09-30   | $1.51B  | -2.21%    |
| 2024-06-30   | $1.50B  | -55.77%   |
| 2024-03-31   | $2.29B  | -3.58%    |

**Analysis:**

*   **Revenue:**  Consistent revenue around $0.63 - $0.65 billion per quarter.
*   **Profit Margin:** Relatively high profit margins, indicating good operational efficiency on the revenue side.
*   **Equity:** Decreasing equity suggests potential financial strain or capital allocation issues.
*   **ROE:** Consistently negative Return on Equity indicates the company is not generating profits from its equity base. The large negative ROE in 2024-06-30 aligns with the significant EPS loss in the same period.

### 7. Overall Analysis

Teladoc Health Inc. (TDOC) exhibits a mixed financial picture. While the company maintains relatively stable revenue and high profit margins, it struggles with profitability, resulting in negative EPS and ROE. The significant underperformance compared to the S&P 500, combined with a negative expected return, suggests considerable risks for long-term investors.

The recent news indicating volatility and major business events highlight the need for caution. Although the short-term moving averages show an upward trend and the MRI indicates low market risk, the high RSI suggests a potential overbought condition.

**Recommendation:** Given the negative profitability, significant underperformance, and mixed signals, a conservative approach is warranted. Monitor the upcoming earnings releases and news for further developments. The Hybrid Signal suggests a cautious buy approach. However, given the significant negative expected return, a long-term investment strategy would be risky without significant improvements in profitability and performance.
